Sorrento moves forward with COVID-19 prophylactic drug

By The Science Advisory Board staff writers

June 5, 2020 -- Sorrento has completed preclinical testing of STI-4398 (COVIDTRAP), reporting positive results on the protein's ability to neutralize and inhibit the SARS-CoV-2 virus from infecting angiotensin-converting enzyme 2 (ACE2)-expressing Vero/E6 cells.

Since the beginning of 2020, Sorrento has been working on therapies against SARS-CoV-2 using a multipronged approach. On May 15, the company announced positive preclinical results from its neutralizing antibody, STI-1499, against SARS-CoV-2 infection. The biologic is pending additional preclinical and clinical studies.

Now, the company believes that STI-4398, a proprietary ACE2-Fc fusion protein, can potently bind to the SARS-CoV-2 spike protein and act as a decoy receptor protein to block viral binding. In vitro assays reveal that STI-4398 inhibited the ability of SARS-CoV-2 to infect Vero/E6 cells at a low concentration.

Sorrento has discussed the development of the drug candidate with the U.S. Food and Drug Administration and has received guidance on a path forward to a clinical trial for COVIDTRAP as a potential prophylactic treatment for COVID-19.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here